Viewing Study NCT03797456


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-01-01 @ 1:36 PM
Study NCT ID: NCT03797456
Status: COMPLETED
Last Update Posted: 2024-04-18
First Post: 2019-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate ICP-022 in Patients With R/R Marginal Zone Lymphoma (MZL)
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module